share_log

UBS Adjusts Shenzhen Kangtai Biological Products’ Price Target to 66 Yuan From 72.50 Yuan, Keeps at Buy

UBS Adjusts Shenzhen Kangtai Biological Products’ Price Target to 66 Yuan From 72.50 Yuan, Keeps at Buy

瑞银将深圳康泰生物制品的目标价从72.50元上调至66元,保持买入状态
MT Newswires ·  2022/08/22 05:16

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发